149 related articles for article (PubMed ID: 33512780)
21. Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator.
Karamanou K; Franchi M; Vynios D; Brézillon S
Semin Cancer Biol; 2020 May; 62():125-133. PubMed ID: 31401293
[TBL] [Abstract][Full Text] [Related]
22. Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells.
Reithmeier A; Panizza E; Krumpel M; Orre LM; Branca RMM; Lehtiö J; Ek-Rylander B; Andersson G
BMC Cancer; 2017 Sep; 17(1):650. PubMed ID: 28915803
[TBL] [Abstract][Full Text] [Related]
23. Stable transfection of an estrogen receptor beta cDNA isoform into MDA-MB-231 breast cancer cells.
Tonetti DA; Rubenstein R; DeLeon M; Zhao H; Pappas SG; Bentrem DJ; Chen B; Constantinou A; Craig Jordan V
J Steroid Biochem Mol Biol; 2003 Oct; 87(1):47-55. PubMed ID: 14630090
[TBL] [Abstract][Full Text] [Related]
24. Virtual screening-driven repositioning of etoposide as CD44 antagonist in breast cancer cells.
Aguirre-Alvarado C; Segura-Cabrera A; Velázquez-Quesada I; Hernández-Esquivel MA; García-Pérez CA; Guerrero-Rodríguez SL; Ruiz-Moreno AJ; Rodríguez-Moreno A; Pérez-Tapia SM; Velasco-Velázquez MA
Oncotarget; 2016 Apr; 7(17):23772-84. PubMed ID: 27009862
[TBL] [Abstract][Full Text] [Related]
25. A novel role of low molecular weight hyaluronan in breast cancer metastasis.
Wu M; Cao M; He Y; Liu Y; Yang C; Du Y; Wang W; Gao F
FASEB J; 2015 Apr; 29(4):1290-8. PubMed ID: 25550464
[TBL] [Abstract][Full Text] [Related]
26. Hyaluronic acid induction on breast cancer stem cells unfolds subtype specific variations in stemness and epithelial-to-mesenchymal transition.
Jariyal H; Gupta C; Srivastava A
Int J Biol Macromol; 2020 Oct; 160():1078-1089. PubMed ID: 32479949
[TBL] [Abstract][Full Text] [Related]
27. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
28. RY10-4 suppressed metastasis of MDA-MB-231 by stabilizing ECM and E-cadherin.
Liu Z; Liu Z; Zhang X; Xue P; Zhang H
Biomed Pharmacother; 2014 May; 68(4):439-45. PubMed ID: 24721328
[TBL] [Abstract][Full Text] [Related]
29. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
30. HAS2 and CD44 in breast tumorigenesis.
Heldin P; Basu K; Kozlova I; Porsch H
Adv Cancer Res; 2014; 123():211-29. PubMed ID: 25081531
[TBL] [Abstract][Full Text] [Related]
31. MDA-MB-231 breast cancer cell viability, motility and matrix adhesion are regulated by a complex interplay of heparan sulfate, chondroitin-/dermatan sulfate and hyaluronan biosynthesis.
Viola M; Brüggemann K; Karousou E; Caon I; Caravà E; Vigetti D; Greve B; Stock C; De Luca G; Passi A; Götte M
Glycoconj J; 2017 Jun; 34(3):411-420. PubMed ID: 27744520
[TBL] [Abstract][Full Text] [Related]
32. Micropatterned surfaces to study hyaluronic acid interactions with cancer cells.
Dickinson LE; Gerecht S
J Vis Exp; 2010 Dec; (46):. PubMed ID: 21206473
[TBL] [Abstract][Full Text] [Related]
33. A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.
Neubauer H; Ruoff A; Paessler N; Solomayer E; Wallwiener D; Fehm T
Oncol Rep; 2009 Feb; 21(2):475-81. PubMed ID: 19148525
[TBL] [Abstract][Full Text] [Related]
34. Recombinant human PRG4 (rhPRG4) suppresses breast cancer cell invasion by inhibiting TGFβ-Hyaluronan-CD44 signalling pathway.
Sarkar A; Chanda A; Regmi SC; Karve K; Deng L; Jay GD; Jirik FR; Schmidt TA; Bonni S
PLoS One; 2019; 14(7):e0219697. PubMed ID: 31361756
[TBL] [Abstract][Full Text] [Related]
35. Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer.
Adamia S; Maxwell CA; Pilarski LM
Curr Drug Targets Cardiovasc Haematol Disord; 2005 Feb; 5(1):3-14. PubMed ID: 15720220
[TBL] [Abstract][Full Text] [Related]
36. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
Bourguignon LY; Singleton PA; Zhu H; Zhou B
J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
[TBL] [Abstract][Full Text] [Related]
37. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
Bourguignon LY; Singleton PA; Zhu H; Diedrich F
J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
[TBL] [Abstract][Full Text] [Related]
39. Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.
Hu C; Li M; Guo T; Wang S; Huang W; Yang K; Liao Z; Wang J; Zhang F; Wang H
Phytomedicine; 2019 May; 58():152740. PubMed ID: 31005718
[TBL] [Abstract][Full Text] [Related]
40. Steviol glycosides affect functional properties and macromolecular expression of breast cancer cells.
Velesiotis C; Kanellakis M; Vynios DH
IUBMB Life; 2022 Oct; 74(10):1012-1028. PubMed ID: 36054915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]